期刊文献+

高效液相色谱-大气压化学电离源-质谱法测定人血浆中帕洛诺司琼浓度 被引量:2

Determination of palonosetron in plasma by HPLC-APCI-MS
下载PDF
导出
摘要 目的:建立液质联用法(HPLC-MS/MS)测定人血浆中帕洛诺司琼浓度的方法。方法:色谱条件为Hypersil GOLD(150.0 mm×4.6 mm,5μm)柱,流动相为0.2%醋酸铵水溶液(含0.1%甲酸)-甲醇(50∶50),质谱条件为大气压化学电离源(AP-CI源),血浆样品中加入内标,碱化后用乙酸乙酯提取,浓缩后采用高效液相色谱-质谱联用进行测定。结果:血浆样品中帕洛诺司琼浓度在0.04~20.00 ng/ml的线性范围内关系良好(r=0.999 9),定量下限为0.04 ng/ml;低、中、高浓度的回收率、批内及批间精密度均符合生物样本测定方法学要求。结论:本方法灵敏度高、专属性强、重现性好,可用于帕洛诺司琼药代动力学研究及血药浓度监测。 Objective:To establish a determination method of palonosetron level in plasma.Methods:LC conditions were as follows:Hypersil GOLD(150 mm × 4.6 mm,5 μm)was used with the mobile phase consisting of acetateamine buffer(0.1% formic acid)-method(50∶50).Equipped with an atmospheric pressure chemical ionization(APCI)source was used as detector.The plasma samples added with internal standard were extracted with Acetic Ether,then concentrated and determined by LC-MS /MS.Results:The linear range of palonosetron was 0.04~20.00 ng /ml.The lower limit of quantification(LLOQ)was 0.04 ng /ml.The recoveries of palonosetron at low,middle and high concentration and the intra-day and inter-day RSDs all met the standards.Conclusion:The established method is sensitive,specific,reproducible and suitable for studies of pharmacokinetics and detection of plasma drug concentration of palonosetron.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第6期903-906,919,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省卫生厅医学科技发展基金资助(P20080)
关键词 帕洛诺司琼 血浆 高效液相 液-质联用法 大气压化学电离源 palonosetron plasma HPLC HPLC-MS/MS APCI
  • 相关文献

参考文献10

二级参考文献38

共引文献70

同被引文献17

  • 1段孝文.紫杉醇联合顺铂氟尿嘧啶治疗晚期复发鼻咽癌的护理及临床意义[J].航空航天医药,2009,20(8):117-119. 被引量:3
  • 2陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:47
  • 3Richard JG. New agents, new treatment and antiemetic therapy [ J ]. Semin Oncol,2002,29( 1 ) :Sl19 - S124.
  • 4Rabasseda X. Ramosetron, a 5 - HT3 receptor antagonist for the control of nausea and vomiting [ J ]. Drugs Today (Barc) , 2002,38 (2) :75 -89.
  • 5Jordan K, Kasper C, Schmoll HJ. Chemotherapy-induced nausea and vomiting:Current and new standards in the antiemetie prophylaxis and treatment[ J]. Eur J Cancer,2005,41 (2) :199.
  • 6Dranitsaris G, Lcung P, Ciotti R, et al. A multinational study to measure the value that patients with cancer place on improved eme- sis control following cisplatin chemotherapy[ J]. Pharmacoeconom- ics,2001,19(9) :955 -967.
  • 7Ingersoll GL, Wasilewski A, Hailer M, et al. Effect of concord grape juice on chemotherapy-induced nausea and vomiting results of a pi- lot study[J]. Oncol Nurs Forum,2010,37(2) :213 -221.
  • 8Ingersoll GL,Wasilewski A, Hailer M,et al. Effect of concord grape juice on chemotherapy-induced nausea and vomiting results of a pi- lot study[J]. Oncol Nurs Forum,2010,37(2):213-221.
  • 9Navafi RM, Reinhardt RR, Gralla R J, et al. Reduction of cisplatin - induced emesis by a selective ncurokinin - 1 - receptor antagonist [J]. N EnglJMed,1999,340(3):190-195.
  • 10杨兆明,郭恩吉.刺法灸法学[M].上海:上海科学技术出版社,1999:131-133.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部